Premium
Smac mimetic enables the anticancer action of BCG‐stimulated neutrophils through TNF‐α but not through TRAIL and FasL
Author(s) -
Jinesh G. Goodwin,
Chunduru Srinivas,
Kamat Ashish M.
Publication year - 2012
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1211623
Subject(s) - fas ligand , tumor necrosis factor alpha , fas receptor , mediator , immunotherapy , apoptosis , cancer research , biology , immunology , tumor microenvironment , pharmacology , immune system , programmed cell death , microbiology and biotechnology , biochemistry
Smac mimetic overcomes resistance of bladder cancer cells to BCG‐stimulated neutrophils through TNF‐α.